biospecimen banks

CPDR Education and Training

Post-doctoral Research

Post-doctoral fellows with M.D. or Ph.D. degrees from the United States and other countries actively participate in the research program and receive state-of-the-art training in basic and translational aspects of cancer research by focusing on prostate cancer. The CPDR is proud of the excellent career advancement that the CPDR trainees have demonstrated. Up to this point, thirty postdoctoral fellows have participated in our program.

 

Education and Training Opportunities for Graduate Students (M.P.H., Ph.D.) and Medical Students (M.D.) of Uniformed Services University of the Health Sciences (USU)

The CPDR offers opportunities for long-term and short-term training of graduate and medical students at USU. Graduate students undertake original research projects focusing on molecular biology, genetics and translational research focusing on prostate cancer. Three graduate students and several medical students have participated so far in the CPDR laboratory projects. One USU-Molecular and Cell Biology Program student completed his Ph.D. thesis at CPDR. One MPH student from the LAM completed his thesis at CPDR.

CPDR POST DOCTORAL FELLOWS 1991 - PRESENT

Jaya Gaddipati, Ph.D (1991-1994)
Axel Heidenreich, MD (1994-1995)
Kekule Asgari, Ph.D (1994-1998)
Linda Xu, MD (1995-1999)
Chun Ling Gao, MD (1997-2002)
Wei Zhang, Ph.D (CPDR & AFIP) (1998-2002)
Takehiko Segawa, MD, Ph.D (1999-2002)
Keiichiro Nakamura, MD, Ph.D (1997-2001)
Yutaka Yasunaga, MD, Ph.D (2000-2001)
Sudhir Rawal, MBBS, MS (2000-2002)
Yongpeng Gu, MD, Ph.D (2000-2006)
Kala Prasanna, Ph.D (2002-2006)
Syed Shaheduzamman, Ph.D (2002-2004)
Chen Sun, MD, Ph.D (2003-2006)
Aijun Liu, MD (2003-2005)
Lionel Banez, MD (2003-2005)
Xiaoqin Fu, Ph.D (2003-2006)
Anu Vishwanath, MD (2003-2004)
Bungo Furusato, Ph.D (2003-2004)
Kee-Hong Kim, BTech, Ph.D (2004-2006)
Katsuaki Masuda, MD, Ph.D (2004-2007)
Govindan Vaidyanathan, Ph.D (2004-2007)
Jun Miki, PhD (2004-2007)
Hongzhen Li, PhD (2007-2009)
Rajesh Thangapazham,Ph.D. ((2008-2009)
Ahmed Mohamed, MD, Ph.D (2006-2009)
Ying Hu, MD.PhD (2006-2009)
Shashwat Sharad, Ph.D (2009-Present)
Shiela Macalindong, MD (2010-2012)
Kristen Nickens, Ph.D (2010-2013)
Nicolas Griner, Ph.D (2011-2013)
Anshu Rastiogi, Ph.D (2011-Present)
Jocelyn Lee, PhD., MPH (2012-Present)
Allissa Dillman, Ph.D (2014-Present)
Indu Kohaar, Ph.D (2014-Present)
Charles Xavier, Ph.D (2014-Present)

CURRENT EVENTS


September 29, 2014

Genomic Health Announces Positive Results from Latest Clinical Validation Study of Oncotype DX® as Predictor of Near- and Long-term Outcomes in Racially Diverse Group of Prostate Cancer Patients

REDWOOD CITY, CA – Genomic Health, Inc. (Nasdaq: GHDX) today announced strongly positive results from an additional independent clinical validation study of the Oncotype DX® prostate cancer test, conducted in collaboration with the Uniformed Services University of the Health Sciences' (USU) Center for Prostate Disease Research (CPDR) supported by a multi-disciplinary team of investigators under a cooperative research and development agreement with USU. This new large study reconfirmed the biopsy-based test's Genomic Prostate Score (GPS) as a predictor of adverse pathology at surgery and, for the first time, validated GPS as a strong independent predictor of a rise in prostate-specific antigen (PSA) following surgery (biochemical recurrence).

Read Full Article.

Read Publication - European Urology

 

WRNMMC UsToo!

Read the NOVEMEBR 2014 Newsletter